CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
CytoDyn Inc.
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026
- Market cap
- $345.56M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
CytoDyn has not reported a dividend
No dividend per share appears in CytoDyn's annual filings since fiscal 2011.